πŸ‡ΊπŸ‡Έ FDA
Patent

US 9562056

Imidazopyridines Syk inhibitors

granted A61KA61K31/437A61K31/444

Quick answer

US patent 9562056 (Imidazopyridines Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/4545, A61K31/496